Dr. Craig Koniver: Peptide & Hormone Therapies for Health, Performance & Longevity

5868.603 - 5888.9 Dr. Craig Koniver

Big money. The concerning part about the GLP-1s is, to me, is what we're starting to see. They've been able to be compounded because there was a shortage. And the way it works with compounding pharmacies is because those are brand – named drugs, and they're not patented for the peptide, right? They're patented for the delivery system, which is the pen, which most people don't realize.